Lixte Biotechnology Holdings effects 1-for-10 reverse stock split

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Reverse stock split effective June 2, 2023; every 10 shares combined into 1.
Stockholders approved the split at a Special Meeting on May 26, 2023.
Common stock begins trading on Nasdaq on a split-adjusted basis June 5, 2023.
No fractional shares issued; any fractional share rounded up to nearest whole share.
Proportionate adjustments made to options, warrants, and Series A Preferred conversion.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LIXTE BIOTECHNOLOGY HOLDINGS, INC.: Filed a Certificate of Amendment to the Certificate of Incorporation to effect a 1-for-10 reverse stock split of common stock, effective June 2, 2023 (effective 2023-06-02).

Change: charter amendment
Effective: 2023-06-02

Exact text from the filing

On June 1, 2023, Lixte Biotechnology Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of its outstanding shares of common stock. The Amendment was effective on June 2, 2023 (the “Effective Time”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-020163

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.